Ireland - English - HPRA (Health Products Regulatory Authority)

dr. august wolff gmbh & co. - oenothera biennis - cream - 200 mg/g

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddy's laboratories australia pty ltd - irbesartan -

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - omeprazole 10mg;   - modified release capsule - 10 mg - active: omeprazole 10mg   excipient: capsugel purple op.c046 capsugel yellow op.c305 crospovidone hypromellose isopropyl alcohol magnesium stearate mannitol meglumine methacrylic acid - ethyl acrylate copolymer opacode black s-1-27794 poloxamer povidone purified water triethyl citrate

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - sertraline hydrochloride 111.92mg equivalent to sertraline 100 mg - film coated tablet - 100 mg - active: sertraline hydrochloride 111.92mg equivalent to sertraline 100 mg excipient: calcium hydrogen phosphate colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry white oy-58900 polysorbate 80 sodium starch glycolate - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - sertraline hydrochloride 55.96mg equivalent to sertraline 50 mg - film coated tablet - 50 mg - active: sertraline hydrochloride 55.96mg equivalent to sertraline 50 mg excipient: calcium hydrogen phosphate colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry white oy-58900 polysorbate 80 sodium starch glycolate - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Ireland - English - HPRA (Health Products Regulatory Authority)

dr. falk pharma gmbh - mesalazine - prolonged-release granules - 1.5 gram(s) - aminosalicylic acid and similar agents; mesalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

dr. falk pharma gmbh - mesalazine - suppository - 1 gram(s) - aminosalicylic acid and similar agents; mesalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

dr. falk pharma gmbh - mesalazine - prolonged-release granules - 1000 milligram(s) - aminosalicylic acid and similar agents; mesalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

dr. falk pharma gmbh - mesalazine - prolonged-release granules - 500 milligram(s) - aminosalicylic acid and similar agents; mesalazine

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - bosentan monohydrate, quantity: 129.082 mg - tablet, film coated - excipient ingredients: maize starch; pregelatinised maize starch; sodium starch glycollate type a; povidone; glycerol dibehenate; magnesium stearate; hypromellose; titanium dioxide; triacetin; purified talc; iron oxide yellow; iron oxide red; ethylcellulose; cetyl alcohol; sodium lauryl sulfate - for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms